6 курс / Гастроэнтерология / Аутоиммунные_заболевания_печени_в_практике_клинициста_Ивашкин_В
.pdf71
h 3. ? " '- " "!,* > %
-> $> ! !' ) > ' +-[Van Thiel D.H. et al., 1995] ) " % $ $ --
= .
`> "$ + % ' > ?`_ ? d + !=-$ +"$ b0_9 (!" ) ' - > ' % ! ! "!,* % +" + " . + "
" " ! + ( )-" "! ; "-
' ! !' ) > ' > % % ' > +-; +" b0_9 13–15 % 1 % -' 1 % . ? !,* $ & )- = ,* " !- + "=- )-. 9 ) ($ b0_9 " = +" &;; [Lindor K.D. et
al., 1996]. )" , %$ +" + " $ +- % ' % '$ ?`_ ! ! . )> , ' b0_9 (!" ) + ) ! ! , !+ " , ! – ' % +"$ $ ?`_, ' !* +- ' = )->.
3.7. L " ( $"
% 4 . ?" &$ |
( , |
+" %" "$ ?`_ +" % ( ( |
<o9 &;;- |
. " " + J.R. Cangemi . (1989)
-$ " ' + ' , ) > ' % - % ' +" +" %" "$ + " =$ + ' , - = + -= = ! %"!++ )-> ' <o9?`_, "- )- -+ -+ +" &-$. )" , +$ + " ( %" ' , $ - &;; , " + ' % '$ <o9 - " -% ( . c $ -+$ +" & - , $ $, +" + ' ; " " -- ! +-% " " '$ "-" "-> "!% -.
f ' ) "-> " !" – . ' = ?`_.
h 3
72
h 3. ? " '- " "!,* > %
# # . " + ' $ " + ($ + '-" +" " + !* ! !' +"- % )-> ?`_. ? - "!+-> ( " , % '$ -=-)-> + " + ( + + ! ?`_ $-90–97%, 5- $$ – 85–88% [Narumi S. et al., 1995; Goss J.A. et al., 1997]. ` = , -= ' " + ) !-
, !' " + > % "(- ( 10% " -
+ ( ). ' +$ " + ( , +" , " " $ " + " % ( "" , >$ " ) % +"$% > + " ( - +" $= "!-;! ( + ' . _! +" % ( " = ' + % )$ ' , +" !,- * )- + " ($ +- - !" "-[Neuberger J. et al., 1999].
- =$ + " + ( % + " ! )-> ?`_:
•" >" ' ! + ' "= " - + , ' +"$* % + " ;
•) "- " !"-;
•$ ) " % ;
•" ) + ' ' " " ;
•; +" ; "- )$.
p " ( ?`_ % 20%, >$, +-!, "- (- -, % $ $ -= + (-" + . b )-> ' ?`_ <o9 " + ($ + ' $ ' <o9, ' " " % ( .
3.8. 1 " ($ -
`" = ?`_ = - !,* : - =$ > ( "" , = + ( ; ' .
. =$ > +" ?`_ +" ' - % '- - +" ? d ( . ". 50), " ( + > '-
73
h 3. ? " '- " "!,* > %
, " ' , $. 9 +" , % ' % &;; ! $ % ! +" ' b0_9.
% $ # # . \-?`_ - =$ + "- % ( "" : " '$ "-" "-> + * , ( , + ' '$ & ( ; +$ ) "- - ; ( . f ' + " ' -> $ +"$ "--. -, " "- '" + ( , + ' , ! -+$ > "!"% ' ! "!,* + " ( + + ! + " % + " . b )-> ?`_ ( " " $ +- )- "- + " , % > !'$> !* > % ! )- " ! + !, + & ! +" + ( " ! $ ($ ' ) .
'# / . 9 & %"!++ = -
$ $:
•"- = ' % +!-"$ +" ;
•" !"- = '-> +" " ( "!,* ) "-- > % ;
•> % "( ;
•+ " - "- -.
g & " $ + ' ! 30% )-> ?`_. ? ! "- %! )- > "-, + %-: )" , + "-> +" " + % >" ' > , - "-> – " ( "!,*$ ) "$ ; ($ +" . -$ + > ,' $ ; $ "$ > % . ! % ' +"- %- +" bY , = - &+ ) " % >- % ! ) % ?`_ != + e#_?h pp_h.( " -+$, ) >- ( & ,, ) & + ' !, > "!"% ' !, & - " ( ,. ?" > "-> " > +" +" +-$> > ! , ' " % = +" ' " + +" + " b0_9.
h 3
74
h 3. ? " '- " "!,* > %
9 ' '- + ; " "!, $ !
15–20% )->. p * % )" !, $ $ $ +"-
% % + ' ' % +" , %! = + " = )- * + ' '- = '- +" . ` " !"- )-' - ; "!, &+ ) " % > % : +$ ! = !> , ! , > " , ) , +" + " ) " .
) "!= " !"- ! )> -+-$ ( % ' % $ $ ,'$ > % "- (-. !' )" ' +" "- " !"- +"-
$, - '$, )$ ($, !
) "-> " "!- + " ( = '->
+" > [Eckhauser F.E. et al., 1996]. " >$ -
$ , ' + " ' " !" +
( "" ' > $> )$ - +-
" ( " )-> ( "" . ? = -
+" + ' $ & + ' " + ' '
( +" , "- |
+"$=- " . ?- |
|
) ( ! 1/ |
3 |
)-> " )! $ + "$ +" (- |
|
|
!" . ? - D.H. Van Thiel . (1995), ! ) "- % ! !' ' ) > ' + ,! 57% )-> )! $ " !" + '-" 29 .
f ' ( b +"$ ) "-
- +" + " " % + " $. K.N. Lazaridis
(1999) !- - !, &;; ( +" ; ( . % "- " !, + !+ "$ " ;- ( !" !, ) +" ; ! ( , +" " *-$ " ( , " !- " "!-> + ( &;; ! !, .
g – = ! 5–20% )-> ?`_, "-
,* $, +" , ( "" ' )
[Broome U., Bergquist A., 2000]. < " + !, > % "(- ! " " + -$ $, ! 10% + ( , "- )--+ " + ($ + ' + + ! ?`_. # "$ > % "(- ( " " , + ; "-
75
h 3. ? " '- " "!,* > %
?`_, , $ !$ +-!, "$
) " % ( ! )-> ) " + , -
"- " , = ! !"$* >. #$$ % +!- > "! , ' & + ' +"-, $ ; !, + ! ?`_. ? - J.K. Ramage . (1995), ! 86% )-> > % "( ; "!, +- - !" " " ` 19-9 `c .
+"- =- $ -, " +" ! -
-> "! ! ( = '-> +" ,
' + " & %" ; .
+ " ' , !'$ > " +$ +" ' - &;;-. % > " + (-> ( " > > %-
"( " " $ ) , +" +
+ " + ' + ' 100% ) = " (- . ?" +" , $ + +- ! !' +" % " + ( ' +" + " ( % !" > +" + " (5-; "-
!" ( ".). ) "!= & +" > +!> -
-> " ( + " "- + " +- $ " " ) -
-> '$.
) = + " % + " +" ?`_ +"-$ )" ) & . b ) ) -! )->, "- )- -+ +" &$ + +-
! <o9. 9" ' & > " )- -,
& " " " ' !, - $ &;;--. +" " = , " " '$ + )- ! ! " X,%!$" % ! " + ' ' % + "- % ! (TIPS). ! !, ' "- ' " " "-> , + *->, + " ->, )-' " = " !, , )-$ != + " + ( + ' .
)* + >- ' , = ?`_ )" =- " . 16.
h 3
76 |
h 3. ? " '- " "!,* > % |
# . 16. % " '$ = ?`_. |
3.9. 9( ( " &
?`_, +" , > " " ! $ >" ' +" %" - "!,* ' . ? - ) "!+ % $, ,' % 174 + ( , "$$ +" =-= +" ?`_ $ 11,9 % [Wiesner R.H. et al.,
77
h 3. ? " '- " "!,* > %
1989]. 0"!% +"$ $ " +"-
= = + 9 17 . , $ =- ) )- " +" %" " )$. , - ) , 45 )- ) +" ?`_ ' " 6,25 % -$ +" %" " )$ ! 76%, > ! 31% " "$ + ' '$ ' , + !- =$ +" ' % > + $ " +- ( + ' . " -
! +" %" " ) + % ?`_ ! 20% + ( ' 63 ) ,$ [Broom U. et
al., 1996].
` " !, " ) +"-> " ! =-+ " " )X$ : -+ "->, ?`_ = -+" ' % > , % "$$ % !- * +" " %!$" ) > ' % % ' -
; -"->, " , ' ' " " +-
) , +" = = ; -"- >, = ' ' ' ) ,$. `- , " !- !'$ % '$ ?`_ )>-"+" " " = .
` +" % ' )$ +" $ $ ) ! =- $ +"$ " " + ' % > "!"% ' % , ' " + ( + '- . ) " +"$ ; ( "
" " , $ +" % ' "-
" , " , -" '- ) "!) , % % ' $ -$ + %$. b , ' =- + " ' -> " " ) +" % ' ( , [Dickson E.R. et al., 1992]. < ( "" ' ?`_ = = + ( , +" % !, ! p- ? ,, ,' ,*!, ( , & ( ; + ,, ( " ( )!-) "!) +" " ) "$.
h 3
78
h 3. ? " '- " "!,* > %
' #
Aadland E., Schrumpf E., Fausa O. et al. Primary sclerosing cholangitis: a long-term follow-up study // Scand. J. Gastroenterol. – 1987. – Vol.22. – P.655–664.
Bansi D.S., Fleming K.A., Chapman R.W. Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG class // Gut. – 1996.
– Vol.34. – P.384–389.
Bergquist A., Glaumann H., Persson B., Broome U. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study // Hepatology. – 1998. – Vol.27. – P.311–316.
Boberg K.M., Lundin K.E.A., Schrumph E. Etiology and pathogenesis of primary sclerosing cholangitis // Scand. J. Gastroenterol. – 1994. – Vol.204. – P.47–58.
Broome U., Bergquist A. Management of primary sclerosing cholangitis in adults // J. Hepatol. – 2000. – Vol.32 (suppl.2). – P.21–22.
Broome U., Olsson R., Loof L. et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis // Gut. – 1996. – Vol.38. – P.610–615.
Chazouilleres O. The variant forms of cholestatic diseases involving small bile ducts in adults // J. Hepatol. – 2000. – Vol.32 (suppl.2). – P.16–18.
Dickson E.R., Murtaugh P.A., Wiesner R.H. et al. Primary sclerosing cholangitis: refinement and validation of survival models // Gastroenterology. – 1992. – Vol.103. – P.1893–1901.
Eckhauser F.E., Colleti L.M., Knol J.A. The changing role of surgery for sclerosing cholangitis // Dig. Dis. Sci. – 1996. – Vol.14. – P.181–190.
El-Shabrawi M., Wilkinson M.L., Portmann B. et al. Primary sclerosing cholangitis in childhood // Gastroenterology. – 1987. – Vol.92. – P.1226–1235.
Goss J.A., Shackleton C.R., Farmer D.G. et al. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience // Ann. Surg. – 1997. – Vol.225. – P.472–481.
Gur H., Shen G., Sutjita M. et al. Autoantibody profile of primary sclerosing cholangitis // Pathobiology. – 1995. – Vol.63. – P.76–82.
Kartheuser A.H., Dozois R.R., LaRusso N.F. et al. Comparison of surgical treatment of ulcerative colitis associated with primary sclerosing cholangitis: ileal pouch-anal anastomosis versus Brooke ileostomy // Mayo Clin. Proc. – 1996. – Vol.71. – P.748–756.
Lazaridis K.N., Wiesner R.H., Porayko M.K. et al. Primary sclerosing cholangitis // In: Schiff’s diseases of the liver. 8th ed. – Lippincott–Raven. – 1999. – P.649–670.
Lindor K.D. Ursodiol for primary sclerosing cholangitis // N. Engl. J. Med. – 1997. – Vol.336. – P.691–695.
Narumi S., Roberts J.P., Emond J.C. et al. Liver transplantation for sclerosing cholangitis // Hepatology. – 1995. – Vol.22. – P.451–457.
Neuberger J., Gunson B., Komolmit P. et al. Pretransplant prediction of prognosis after liver transplantation in primary sclerosing cholangitis // Hepatology. – 1999. – Vol.29. – P.1375–1379.
Olsson R., Danielsson A., Jarnerot G. et al. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis // Gastroenterology. – 1991. – Vol.100. – P.1319–1323.
Van Milligen de Wit A.W.M., Van Deventer S.J.H., Tytgat G.N.J. Immunogenetic aspects of primary sclerosing cholangitis: implications for therapeutic strategies // Am. J. Gastroenterol. – 1995. – Vol.90. – P.893–900.
Wiesner R.H., Grambsch P.M., Dickson E.R. et al. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis // Hepatology. – 1989. – Vol.10. – P.430–436.
79
h 4. 9 ) "- + " " - ! !- "-
4.? " " -
) "- ! !- "-
4.1." #$ % &
9 !+ -, , ) "!=- +" !- ; " ! ) % ' *- - % ! 95% )->, +" $, ) %- " %- ' % ' " " ? d. b ' )--> ? d -$ $, , >$ , $ > " "- --) > ' % % ' +" ? d +" & " ) "!= , ANA, SMA "!% ! . 0 -$* % " ; " " % $ + +- ! $ & + % % ' ; " . < ) ' & " ) ' , + +- d b. 9 +" , ' ! ! % > %+ ( ; ' > ' " , ' $ +" + = = " ( + + " % ( " ( . - " +$ " " ! > )-> )-' &;;;-
h 4
80
h 4. 9 ) "- + " " - ! !- "-
, > ' !* $ $ + )* +" $ )-> ? d.
d d % / !* > " " ! $" ) > ) ) , $ ! 9% )- * % ' )-> ? d. b ) % - ? d % + " " % " ! , +" ' 24 !,* > " " [Chazouielleres O., 1998, 2000]:
•f 5 " ;
•IgG 2 " ;
•SMA % ' " ;
•+ " + "- !+ '- "-.
$ '$ ( ($ " h/? d HLA B8, DR3 DR4. -" +"$, $ " )"- !- , +" & ) + ' ) ($ , ANA SMA.
p -$ $ ! )-> h, + "- -,$ 25%, > " )-' % % - ' % '$. 9" % , +" h, +" , )- , + ( ; ' , $ ? d, >$ 8% !' ) ,- $ -" ) + '-> % ! ! " )"-- > " 2. ` ! = = =- + % " ! +" +"$ !-
; , " ( ( ! > ; , " ( "-
-LKM-1.
h % ' -$ $, !+ '- "- '
+ " ! !$" ; " ( + "-> " "!-
( = '-> +" . ` " h/? d +" %" |
"! )- - |
" , ' + '- ? d, +" & " +" %" |
"$ |
"" "! -" = , +-" ' > -+ " >- + ' . b % > )-> -, $ &;- ;- " "-, ' +$ +" $ - % " +" ) ' - +"$ '$ h " 3–6 . O. Chazouilleres (1998) !--- !, &;; ) ( +" b0_9, +" " +" = , + "-! ) + ( .